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Abstract
Background: Multi-slice computed tomography (MSCT) is a fast-growing technology that
permits a non-invasive, yet reliable, assessment of coronary atherosclerosis. We sought to
explore the diagnostic accuracy of MSCT angiography in the detection of significant stenosis of
the left main coronary artery (LMCA) in a series of patients with an intermediate pre-test
likelihood of coronary artery disease (CAD).
Methods: We prospectively enrolled 30 consecutive patients with an intermediate pre-test
likelihood of CAD. Patients underwent 64-slice MSCT angiography to detect significant stenosis
of the LMCA (defined as ≥ 50% luminal obstruction). They subsequently underwent invasive
coronary angiography according to the standard technique.
Results: The mean age was 52.7 ± 6.3 years, 24 (80%) being males. Three (10%) patients
had significant stenosis of the LMCA by invasive coronary angiography, while four (13.3%)
patients were categorized as having significant LMCA stenosis by MSCT coronary angiography.
MSCT coronary angiography was able to detect significant LMCA stenosis with a sensitivity
of 100%, specificity of 96.3%, positive and negative predictive values of 75% and 100% respec-
tively, and a diagnostic accuracy of 96.7%, with reference to invasive coronary angiography.
Conclusions: In patients with an intermediate pre-test likelihood of CAD, MSCT coronary
angiography provides a highly accurate diagnostic modality for ruling out significant LMCA
stenosis, with reference to invasive coronary angiography. (Cardiol J 2010; 17, 6: 594–598)
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Introduction
Multi-slice computed tomography (MSCT) is
a rapidly advancing technology that permits a non-
-invasive, yet reliable, assessment of coronary ath-
erosclerotic disease. An accumulating body of evi-
dence has demonstrated a consistently high sensi-
tivity and specificity for the detection of significant
coronary stenosis, as compared to standard invasive
coronary angiography [1–4]. Yet, based on its high
negative predictive value, it has become an accept-
ed diagnostic option to exclude coronary artery di-
sease (CAD) in patients with chronic stable angina
pectoris; a normal MSCT scan almost rules out sig-
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nificant coronary stenosis [5, 6]. Furthermore,
a normal MSCT foretells a good prognosis at mid-
term follow-up, which compares favorably with that
of a normal coronary angiogram [7].
The prevalence of a normal MSCT in a popula-
tion with suspected CAD depends on the pre-test
likelihood of the disease. The yield of a normal scan
was highest in patients with low or intermediate
pre-test likelihood of coronary disease [8]. In a po-
pulation with a Bayesian distribution, MSCT angio-
graphy (being a non-invasive test) is expected to
have the greatest impact on supporting or ruling out
the diagnosis of significant CAD in subjects with an
intermediate pre-test likelihood of the disease.
In a prospective study design, we sought to
explore the diagnostic accuracy of MSCT angio-
graphy for the detection of significant stenosis of
the left main coronary artery (LMCA) in a series of
patients with an intermediate pre-test likelihood of
CAD, based on an ‘intention-to-diagnose’ analysis.
Methods
Patient selection
We prospectively enrolled 30 consecutive pa-
tients referred to our cath labs between March and
August 2007 to undergo elective invasive coronary
angiography for suspected CAD. Patients were con-
sidered eligible for inclusion if they had an inter-
mediate pre-test likelihood of CAD as defined by:
1) ischemic-type chest pain or other symptoms
suggestive of myocardial ischemia in the absence
of a positive stress test or with an equivocal stress
test for myocardial ischemia or 2) asymptomatic
patient with a positive stress test. We excluded
patients with a history of CAD as defined by sig-
nificant coronary stenosis shown in prior coronary
angiogram, prior myocardial infarction, prior per-
cutaneous coronary intervention, or prior coronary
artery bypass surgery. We also excluded patients
with atrial fibrillation and those at risk for iodinat-
ed contrast agents (dye allergy or elevated serum
creatinine > 1.8 mg/dL). Before inclusion, an in-
formed written consent was obtained from each
patient after full explanation of the study protocol,
and the study protocol was reviewed and approved
by our local institutional human research commit-
tee as it conforms to the ethical guidelines of the
1975 Declaration of Helsinki, as revised in 2002.
Definition of risk factors
The presence of hypertension was defined as
a systolic blood pressure ≥ 140 mm Hg and/or a dia-
stolic blood pressure ≥ 90 mm Hg, previously re-
corded by repeated non-invasive office measure-
ments, which lead to life-style modification or anti-
hypertensive drug therapy. The presence of diabe-
tes mellitus was defined as a fasting plasma glucose
≥ 126 mg/dL, and/or a two-hour postload glucose
≥ 200 mg/dL, or specific anti-diabetic drug thera-
py. Dyslipidemia was defined as an LDL choleste-
rol > 100 mg/dL, and/or a serum triglycerides
> 150 mg/dL, and/or an HDL cholesterol < 40 mg/dL
in men and < 50 mg/dL in women.
MSCT, image acquisition
MSCT examinations were performed with a 64-
-slice scanner (Aquilion 64, Toshiba Medical Sys-
tems, Otawara, Japan). First, a non-contrast-en-
hanced scan was performed prior to MSCT coro-
nary angiography to assess the total coronary
calcium burden. For this initial scan, collimation was
4 × 3.0 mm and gantry rotation time 500 ms. Tube
voltage and tube current were 120 kV and 200 mA,
respectively.
The scan parameters for the standard exami-
nation were: collimation 64 × 0.6 mm and rotation
time 370 ms. Tube current and tube voltage were
680 mA and 120 kV respectively, with a 0.24 pitch.
The total amount of contrast (Iopromide, Ultravist®
300, 300 mg I/mL, Bayer HealthCare Pharmaceu-
ticals Inc., Wayne, Germany) was 80–120 mL inject-
ed into an antecubital vein, followed by a 50-mL
saline chaser, both injected at a rate of 5 mL/s.
Automated detection of peak enhancement in the
aortic root was used to time the scan. In all patients,
imaging was performed with breath held in inspira-
tion and under retrospective electrocardiographic
gating. In patients with a heart rate > 65 beats/mi-
nute, beta-blocking agents were administered prior
to MSCT imaging if no contraindications for beta-
-blockade were present. To assess the presence
of coronary artery plaques, reconstructions were
generated in diastole (typically 75% of the cardiac
cycle). Slice thickness was 0.5 mm with an incre-
ment of 0.3 mm. In case of motion artifacts, addi-
tional reconstructions were explored at different
time points of the R-R interval. Thereafter, the
axial data sets were transferred to a remote work-
station (Wizard, Siemens Medical Solutions, Forch-
heim, Germany) for post-processing and subse-
quent interpretation.
MSCT, image interpretation
All data was evaluated on the remote worksta-
tion using dedicated software. Two experienced
independent investigators, blinded to clinical data,
evaluated the contrast-enhanced computed tomo-
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graphy scans by assessment of axial slices, as well
as post-processing images, including: multiplanar
reformations, maximum intensity projections, and
volume rendering technique. Orientated along the
heart axis, the thin-slab (5 mm thickness, 1 mm in-
crement) maximum intensity projections were re-
constructed perpendicular to each other, resulting
in the traditional cardiac short- and long-axis views,
as well as the ’four-chamber’ view. A semi-automa-
tic analysis tool was used for the assessment of se-
verity of LMCA stenosis on curved multiplanar re-
formations and cross-sections orthogonal to the ves-
sel. Significant stenosis of the LMCA was defined
by at least 50% luminal diameter obstruction. Ac-
cording to an ’intention-to-diagnose’-based analy-
sis, arteries with inconclusive segments were con-
sidered as significantly diseased.
Invasive coronary angiography
All patients underwent selective left and right
coronary arteriography using the standard tech-
nique within one week of MSCT examinations.
Angiographic data was retrospectively analyzed by
a single expert independent interventionalist, blind-
ed to both the clinical data and the results of MSCT
coronary angiography. No intracoronary pharmaco-
logic agents were given. Significant stenosis of the
LMCA was defined as at least 50% luminal diame-
ter obstruction seen in two different projections. In
lesions with borderline significance, an automated
edge detection system (Integris 3000, Philips Medi-
cal Systems, the Netherlands) was applied to de-
termine lesion severity.
Statistical analysis and study endpoint
The analysis of data was performed on an ‘in-
tention-to-diagnose’ basis, including all enrolled
patients. In this regard, stenotic segments deter-
mined as inconclusive by MSCT angiography be-
cause of extensive coronary calcification or severe
motion artifacts were considered as significantly
diseased by MSCT.
The primary endpoint of the study was the ac-
curacy of MSCT angiography to detect significant
stenosis of the LMCA, with reference to invasive
angiography. Patients were classified as having sig-
nificant stenosis of the LMCA if they had at least
50% luminal obstruction by invasive angiography,
which was regarded as the standard of reference.
All continuous variables were presented as
mean ± standard deviation, if they were normally
distributed. Data was tested for normal distribution
using the Kolmogorov-Smirnov test. Categorical
variables were described with absolute and relative
(percentage) frequencies. The sensitivity, specifi-
city, positive and negative predictive values and
diagnostic accuracy were calculated according to the
standard definitions. Analyses were performed with
SPSS version 12.0 statistical package (SPSS Inc.,
Chicago, Illinois, USA).
Results
Baseline clinical characteristics
A total of 30 consecutive patients were prospec-
tively enrolled in the current study. Table 1 shows
the baseline clinical characteristics of the whole se-
ries. The mean age was 52.7 ± 6.3 years, 24 (80%)
being males. Among the series patients, 19 (63.3%)
were smokers, 26 (86.7%) were hypertensive,
15 (50%) were diabetic, and 15 (50%) had dyslipidemia.
The mean Agatston calcium score was 227 ± 688.
Angiographic data
Based on the aforementioned definition, three
(10%) patients had significant stenosis of the LMCA
by invasive coronary angiography. Moreover,
18 (60%) patients had significant stenosis of the left
anterior descending artery, 11 (36.7%) patients had
significant stenosis of the right coronary artery, and
three (10%) patients had significant stenosis of the
circumflex artery.
On the other hand, four (13.3%) patients were
categorized as having significant stenosis of the
LMCA by MSCT coronary angiography. MSCT coro-
nary angiography was able to detect significant
LMCA stenosis with a sensitivity of 100%, speci-
ficity of 96.3%, positive and negative predictive
values of 75% and 100% respectively, and a diag-
nostic accuracy of 96.7%.
Moreover, no patient reported any clinical
events during the period from MSCT examinations
to invasive coronary angiography.
Table 1. Baseline characteristics of the study series
(total cohort: n = 30).
Age (years) 52.6 ± 6.3
Males 24 (80%)
Diabetes 15 (50%)
Hypertension 26 (86.7%)
Smoking 19 (63.3%)
Dyslipidemia 15 (50%)
Continuous variables are presented as mean ± standard deviation,
while categorical variables are presented as numbers (percentage).
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Discussion
The current study has demonstrated that
MSCT angiography was able to identify significant
stenosis of the LMCA with a high diagnostic accu-
racy in patients with an intermediate pre-test like-
lihood of CAD, based on an ’intention-to-diagnose’
analysis. The negative predictive value of 100%
reliably ruled out patients with significant LMCA
disease in this patient category.
Invasive coronary angiography still remains the
‘gold standard’ for diagnosis of CAD. In this con-
text, significant CAD is still being excluded by this
invasive technique in a large proportion of patients
with an intermediate pre-test probability of CAD.
To avoid ‘unnecessary’ invasive testing in this ‘not-
-a-high-risk’ patient category, an accurate reprodu-
cible, yet safe, non-invasive diagnostic modality is
highly desirable. Several prior studies demonstra-
ted the high diagnostic accuracy of MSCT angiogra-
phy to detect significant (50%) coronary stenosis
[9–15]. However, a major limitation of these stu-
dies was the enrollment of patients with a wide spe-
ctrum of pre-test probabilities of having CAD. Fur-
thermore, patients with already-known CAD, in-
cluding those with prior percutaneous coronary
intervention and those who underwent coronary by-
pass surgery, were also enrolled [9–15]. On the
contrary, the current study has focused on patients
an intermediate pre-test likelihood of having CAD,
a category in which the diagnostic value of a non-
invasive technique would be greatest, and hence,
the implementation of this novel technology would
be most rewarding.
Stress imaging studies, such as stress myocar-
dial perfusion imaging with radioisotope scintigra-
phy or dobutamine stress echocardiography, are
widely used as non-invasive diagnostic tools for
diagnosis/ruling out of significant CAD in patients
with low or intermediate pre-test likelihood of coro-
nary disease [16, 17]. Nevertheless, many patients
risk developing myocardial infarction, even sudden
cardiac death, when exposed to the fairly arduous
stress inherent to exercise [18]. Therefore, employ-
ing a non-invasive technique for appropriately tria-
ging patients with angina, to further invasive dia-
gnostic work-up mandates an adequately high safety
profile of the technique adopted. In this sense,
MSCT angiography, being devoid of stress, would
offer an excellent non-invasive diagnostic tool for
stratifying patients on the basis of their need for
invasive coronary angiography. Furthermore, visu-
alization of atheromatous plaques in the LMCA
beforehand would add to the safety of the ensuing
invasive angiography procedure. Deep catheter in-
sertion in the LMCA during invasive coronary an-
giography might inadvertently disrupt an ostial or
very proximal atheroma, especially if the catheter
tip was not coaxial with the LMCA trunk, ending in
a catastrophic dissection of the LMCA [19, 20]. The
excellent negative predictive value of MSCT to rule
out a LMCA atheroma (100%) provides an efficient
‘safety net’ for reassuring the operator during in-
vasive angiography about the absence of such an
‘obstacle to pass’. This valuable piece of informa-
tion is obviously not offered by the various stress
imaging studies. Additionally, characteristics inher-
ent to stress imaging studies limit definite exclu-
sion of coronary atherosclerosis, since non-obstruc-
tive atheromatous plaques cannot be excluded.
There is a poor association between the amount of
atherosclerotic burden and the occurrence of clini-
cal events [21]. Therefore, these non-obstructive
plaques (not detected by stress imaging studies)
might be the ‘seat’ of plaque ulceration and throm-
bosis with the ensuing occurrence of acute coronary
syndrome.
The ‘intention-to-diagnose’-based analysis
adopted in the current study, entailing the assign-
ment of ‘inconclusive segments’ as significantly
diseased ones might have reduced the specificity
and the positive predictive value of MSCT to diag-
nose significant LMCA stenosis (96.3% and 75%
respectively). Extensive coronary calcification was
previously identified as a substantial problem for the
interpretation of MSCT coronary angiograms and
the detection of coronary stenoses, essentially due
to the blooming effect and beam hardening [10].
Clinical implications
The extremely high sensitivity and negative
predictive value of MSCT coronary angiography to
detect significant LMCA stenosis in patients with
an intermediate pre-test likelihood of CAD, as dem-
onstrated in the current study, would provide an
attractive means of ruling out this high-risk condi-
tion in this patient category. A normal LMCA by
MSCT coronary angiography virtually excludes
LMCA stenosis by invasive coronary angiography.
Even when MSCT coronary angiography demon-
strates significant disease of other coronary arteries/
/segments, exclusion of LMCA disease would provide
reassurance to the operator during invasive coronary
angiography that no ‘obstacles’ remain in his way to
inserting the catheter into the LMCA. On the other
hand, visualization of an atheromatous plaque in the
LMCA would set a ‘red-light flash’ that maximum care
during cannulation of the LMCA should be taken.
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Limitations of the study
Our findings are based on a single center study
with a relatively small sample size of the cohort,
a fact that makes it difficult to generalize our re-
sults to all patients with an intermediate pre-test
likelihood of CAD. Multi-center studies employing
the same protocol and examining a larger number
of patients are needed. Moreover, it is uncertain
that the results of the current study can be safely
extrapolated to patients with high or low pre-test
likelihood of CAD. In addition,  imaging of adequate
quality requires patients with stable and preferably
lower heart rates, resulting in a frequent need for
the administration of beta blocking agents prior to
MSCT angiography. Limitations inherent to the
technique include the administration of a potentially
nephrotoxic contrast medium and the associated
radiation exposure. Despite the application of radia-
tion dose-saving algorithms, the radiation dose es-
timates are almost doubled with 64-slice MSCT an-
giography as compared to the old 16-slice systems.
This increase in dose, however, resulted in a signi-
ficant reduction in the number of inconclusive seg-
ments, with a subsequent improvement of the test
specificity to detect significant coronary stenosis.
Conclusions
In patients with an intermediate pre-test like-
lihood of CAD, MSCT coronary angiography pro-
vides an accurate diagnostic modality for detection
of significant LMCA stenosis, with reference to in-
vasive coronary angiography. Its extremely high
negative predictive value in this regard provides an
attractive means of ruling out this high-risk condi-
tion in such an intermediate-risk patient category.
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